Ivan Hyep
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $3.2M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 12SEC | BCAXBicara Therapeutics Inc. | Sell Plan | 12,500129,855 held (−9%) | $27.97 | $350K | -37.4% |
| Jul 10SEC | BCAXBicara Therapeutics Inc. | Sell Plan | 22,757135,098 held (−14%) | $28.60 | $651K | -38.8% |
| Jul 10SEC | BCAXBicara Therapeutics Inc. | Sell Plan | 4,413130,685 held (−3%) | $29.82 | $132K | -41.3% |
| Jul 10SEC | BCAXBicara Therapeutics Inc. | Sell Plan | 830129,855 held (−1%) | $30.31 | $25K | -42.3% |
| May 26SEC | BCAXBicara Therapeutics Inc. | Sell Plan | 9,200145,355 held (−6%) | $20.42 | $188K | -14.3% |
| Apr 22SEC | BCAXBicara Therapeutics Inc. | Sell Plan | 9,200145,355 held (−6%) | $23.00 | $212K | -23.9% |
| Mar 24SEC | BCAXBicara Therapeutics Inc. | Sell Plan | 9,200145,355 held (−6%) | $18.52 | $170K | -5.5% |
| Mar 5SEC | BCAXBicara Therapeutics Inc. | Sell Plan | 13,555145,355 held (−9%) | $18.22 | $247K | -4.0% |
| Mar 5SEC | BCAXBicara Therapeutics Inc. | Sell Plan | 2,963145,355 held (−2%) | $18.25 | $54K | -4.1% |
| Jan 26SEC | BCAXBicara Therapeutics Inc. | Sell Plan | 1,882145,355 held (−1%) | $18.15 | $34K | -3.6% |
| Dec 23SEC | BCAXBicara Therapeutics Inc. | Sell Plan | 9,200145,355 held (−6%) | $18.31 | $168K | -4.4% |
| Nov 25SEC | BCAXBicara Therapeutics Inc. | Sell Plan | 605145,355 held (−0%) | $18.15 | $11K | -3.6% |
| Nov 25SEC | BCAXBicara Therapeutics Inc. | Sell Plan | 17,795145,355 held (−11%) | $18.55 | $330K | -5.7% |
| Oct 10SEC | BCAXBicara Therapeutics Inc. | Sell Plan | 6,415145,355 held (−4%) | $18.23 | $117K | -4.0% |
| Oct 8SEC | BCAXBicara Therapeutics Inc. | Sell Plan | 6,514145,355 held (−4%) | $18.17 | $118K | -3.7% |
| Oct 8SEC | BCAXBicara Therapeutics Inc. | Sell Plan | 18,244145,355 held (−11%) | $18.22 | $332K | -4.0% |
| Oct 8SEC | BCAXBicara Therapeutics Inc. | Sell Plan | 5,627145,355 held (−4%) | $18.21 | $102K | -3.9% |
- Sell
CFO Ivan Hyep sold $350K of BCAX at $27.97 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Ivan Hyep sold $651K of BCAX at $28.60 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Ivan Hyep sold $132K of BCAX at $29.82 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Ivan Hyep sold $25K of BCAX at $30.31 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Ivan Hyep sold $188K of BCAX at $20.42 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Ivan Hyep sold $212K of BCAX at $23.00 — pre-scheduled 10b5-1 plan sale.